JPMORGAN CHASE & CO - LEAP THERAPEUTICS INC ownership

LEAP THERAPEUTICS INC's ticker is LPTX and the CUSIP is 52187K101. A total of 72 filers reported holding LEAP THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 0.18 and the average weighting 0.1%.

Quarter-by-quarter ownership
JPMORGAN CHASE & CO ownership history of LEAP THERAPEUTICS INC
ValueSharesWeighting
Q1 2023$1,000
+99900.0%
3,374
+48.1%
0.00%
Q4 2022$1
-100.0%
2,278
-63.2%
0.00%
Q3 2022$5,0000.0%6,190
+48.9%
0.00%
Q2 2022$5,000
-72.2%
4,156
-60.6%
0.00%
Q1 2022$18,000
-28.0%
10,542
+35.4%
0.00%
Q4 2021$25,000
-72.8%
7,786
-80.9%
0.00%
Q4 2020$92,00040,862
+272313.3%
0.00%
Q3 2020$0
-100.0%
15
-100.0%
0.00%
Q2 2020$1,148,000
+934.2%
549,184
+3752.3%
0.00%
Q3 2018$111,000
-67.0%
14,256
-64.8%
0.00%
Q1 2018$336,000
+33500.0%
40,503
+39223.3%
0.00%
Q4 2017$1,0001030.00%
Other shareholders
LEAP THERAPEUTICS INC shareholders Q2 2022
NameSharesValueWeighting ↓
Asymmetry Capital Management, L.P. 900,733$1,883,0001.44%
Sio Capital Management, LLC 1,501,998$3,139,0000.92%
CVI Holdings, LLC 704,900$1,473,0000.55%
Perceptive Advisors 8,476,496$17,466,0000.28%
Artal Group S.A. 2,974,000$6,216,0000.17%
SPHERA FUNDS MANAGEMENT LTD. 880,000$1,839,0000.17%
DAFNA Capital Management LLC 275,000$575,0000.17%
J. Goldman & Co LP 1,018,285$2,128,0000.13%
MYDA Advisors LLC 100,000$209,0000.13%
683 Capital Management, LLC 526,466$1,100,0000.09%
View complete list of LEAP THERAPEUTICS INC shareholders